"With neuroscience as part of Janssen's origin story, we are focused on brain health, actively searching for solutions for all the people living with disorders of the nervous system."
Bill Martin, Ph.D.
GLOBAL THERAPEUTIC AREA HEAD
The Janssen Research & Development Neuroscience team is focused on neurodegenerative disorders, such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease; neurological/neuromuscular diseases, such as myasthenia gravis and epilepsy; and neuropsychiatric disorders, such as major depressive disorder, bipolar disorder, schizophrenia, and autism.
Despite several advancements in neuroscience over the past 60 years, unmet need persists for patients across a broad range of these kinds of disorders. However, there has been significant progress in understanding and treating these diseases, and at Janssen, we never stop pushing the boundaries of what is possible.
Learn more about the Neuroscience Therapeutic Area.